Simon Travis mainly investigates Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Surgery and Gastroenterology. His study in the fields of Mesalazine under the domain of Inflammatory bowel disease overlaps with other disciplines such as Context. His studies in Ulcerative colitis integrate themes in fields like Physical therapy, Clinical trial, Colitis and Pharmacotherapy.
He combines subjects such as Colectomy, Management of Crohn's disease and Intensive care medicine with his study of Surgery. His Gastroenterology research is multidisciplinary, incorporating perspectives in Colonoscopy, Sigmoidoscopy and Placebo. His biological study spans a wide range of topics, including Evidence-based practice, Intestinal mucosa, Immunology and Single-nucleotide polymorphism.
His scientific interests lie mostly in Internal medicine, Ulcerative colitis, Gastroenterology, Inflammatory bowel disease and Crohn's disease. Many of his studies involve connections with topics such as Surgery and Internal medicine. His Surgery research includes themes of Odds ratio and Placebo.
His study looks at the relationship between Ulcerative colitis and topics such as Colitis, which overlap with Management of ulcerative colitis. His Gastroenterology study combines topics from a wide range of disciplines, such as Budesonide, Mesalazine, Adverse effect, Calprotectin and Colonoscopy. Simon Travis has included themes like Quality of life, Immunology and Primary sclerosing cholangitis in his Inflammatory bowel disease study.
His scientific interests lie mostly in Internal medicine, Ulcerative colitis, Inflammatory bowel disease, Crohn's disease and Gastroenterology. Simon Travis merges Internal medicine with In patient in his study. His Colectomy study, which is part of a larger body of work in Ulcerative colitis, is frequently linked to Calculator, bridging the gap between disciplines.
His Inflammatory bowel disease research includes elements of Exome sequencing, Malignancy, Immunology and Intensive care medicine. His research on Crohn's disease concerns the broader Disease. As a part of the same scientific family, he mostly works in the field of Gastroenterology, focusing on Confidence interval and, on occasion, Histopathology, Area under the curve and Receiver operating characteristic.
Internal medicine, Inflammatory bowel disease, Crohn's disease, Gastroenterology and Ulcerative colitis are his primary areas of study. Simon Travis performs integrative study on Internal medicine and In patient. Simon Travis has researched Inflammatory bowel disease in several fields, including Immunology, Transplantation and Intensive care medicine.
His Crohn's disease study is focused on Disease in general. His work carried out in the field of Gastroenterology brings together such families of science as Osteomalacia, Refractory and Surrogate endpoint. Many of his research projects under Ulcerative colitis are closely connected to MedDRA with MedDRA, tying the diverse disciplines of science together.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass;G. Van Assche;J.O. Lindsay;M. Lémann.
Journal of Crohns & Colitis (2010)
Guidelines for the management of inflammatory bowel disease in adults
M J Carter;A J Lobo;S P L Travis.
Gut (2004)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
L. Peyrin-Biroulet;W. Sandborn;B. E. Sands;W. Reinisch;W. Reinisch.
The American Journal of Gastroenterology (2015)
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber;Bruce E Sands;Steve Lewitzky;Marc Vandemeulebroecke.
Gut (2012)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
Gert Van Assche;Axel Dignass;Julian Panes;Laurent Beaugerie.
Gut (2006)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass;James O. Lindsay;Andreas Sturm;Alastair Windsor.
Journal of Crohn's and Colitis (2012)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
Gert Van Assche;Axel Dignass;Walter Reinisch;C. Janneke van der Woude.
Journal of Crohns & Colitis (2010)
Second European Evidence-Based Consensus on the Diagnosis and Management of Ulcerative Colitis Part 1: Definitions and Diagnosis
Axel Dignass;Rami Eliakim;Fernando Magro;Christian Maaser.
Journal of Crohn's and Colitis (2012)
Mucosal healing in inflammatory bowel diseases: a systematic review
Markus F Neurath;Simon P L Travis.
Gut (2012)
Predicting outcome in severe ulcerative colitis.
S. P. L. Travis;J. M. Farrant;C. Ricketts;D. J. Nolan.
Gut (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, San Diego
Medical University of Vienna
University of Western Ontario
Humanitas University
Icahn School of Medicine at Mount Sinai
University of Calgary
University of Lorraine
University of Amsterdam
NHS Blood and Transplant
University of Barcelona
Wageningen University & Research
National Technical University of Athens
University of Hannover
Pennsylvania State University
University of California, San Francisco
City Of Hope National Medical Center
Wisconsin Department of Natural Resources
KU Leuven
Johns Hopkins University
Peking Union Medical College Hospital
University College London
University of California, Berkeley
University of Colorado Boulder
Chinese Academy of Sciences
University of Geneva
University of North Carolina at Chapel Hill